{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:24:12Z","timestamp":1793593452430,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Plan Project of Natural Science Foundation of Fujian Province","award":["2021J011345"],"award-info":[{"award-number":["2021J011345"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03082-1","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:51:03Z","timestamp":1751374263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of tertiary lymphoid structure-associated biomarkers on pancreatic cancer via a dual-disease analysis of psoriasis and pancreatic cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Hao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Xing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Huan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Yuan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"3082_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18:493\u2013502. https:\/\/doi.org\/10.1038\/s41575-021-00457-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3082_CR2","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.7314\/apjcp.2015.16.14.5619","volume":"16","author":"V Goral","year":"2015","unstructured":"Goral V. Pancreatic cancer: pathogenesis and diagnosis. Asian Pac J cancer Prevention: APJCP. 2015;16:5619\u201324. https:\/\/doi.org\/10.7314\/apjcp.2015.16.14.5619.","journal-title":"Asian Pac J cancer Prevention: APJCP"},{"key":"3082_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/s0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet (London England). 2011;378:607\u201320. https:\/\/doi.org\/10.1016\/s0140-6736(10)62307-0.","journal-title":"Lancet (London England)"},{"key":"3082_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology. 2023;164:752\u201365. https:\/\/doi.org\/10.1053\/j.gastro.2023.02.012.","journal-title":"Gastroenterology"},{"key":"3082_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","volume":"520","author":"J Cai","year":"2021","unstructured":"Cai J, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis. Cancer Lett. 2021;520:1\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2021.06.027.","journal-title":"Cancer Lett"},{"key":"3082_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jconrel.2020.07.016","volume":"326","author":"YE Lee","year":"2020","unstructured":"Lee YE, et al. Rationally designed Redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatment. J Controll Release: Off J Controll Release Soc. 2020;326:310\u201323. https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.016.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"3082_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41571-019-0281-6","volume":"17","author":"C Nevala-Plagemann","year":"2020","unstructured":"Nevala-Plagemann C, Hidalgo M, Garrido-Laguna I. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer. Nat Rev Clin Oncol. 2020;17:108\u201323. https:\/\/doi.org\/10.1038\/s41571-019-0281-6.","journal-title":"Nat Rev Clin Oncol"},{"key":"3082_CR8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/s0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP, Psoriasis. Lancet (London England). 2015;386:983\u201394. https:\/\/doi.org\/10.1016\/s0140-6736(14)61909-7.","journal-title":"Lancet (London England)"},{"key":"3082_CR9","doi-asserted-by":"publisher","unstructured":"Gosia M, Doshi G, Bagwe Parab S, Godad A. Innovative approaches to psoriasis: small molecules targeting key signaling pathways. Immunol Investig. 2025;1\u201337. https:\/\/doi.org\/10.1080\/08820139.2025.2449960.","DOI":"10.1080\/08820139.2025.2449960"},{"key":"3082_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.12122\/j.issn.1673-4254.2025.01.12","volume":"45","author":"Q Liu","year":"2025","unstructured":"Liu Q, et al. Quercetin mediates the therapeutic effect of Centella asiatica on psoriasis by regulating STAT3 phosphorylation to inhibit the IL-23\/IL-17A axis. Nan Fang Yi Ke Da Xue Xue bao = J South Med Univ. 2025;45:90\u20139. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2025.01.12.","journal-title":"Nan Fang Yi Ke Da Xue Xue bao = J South Med Univ"},{"key":"3082_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jamadermatol.2020.0024","volume":"156","author":"S Vaengebjerg","year":"2020","unstructured":"Vaengebjerg S, Skov L, Egeberg A, Loft ND. Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis. JAMA Dermatol. 2020;156:421\u20139. https:\/\/doi.org\/10.1001\/jamadermatol.2020.0024.","journal-title":"JAMA Dermatology"},{"issue":"3","key":"3082_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/jdv.12165","volume":"27","author":"C Pouplard","year":"2013","unstructured":"Pouplard C, et al. Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol: JEADV. 2013;27(3):36\u201346. https:\/\/doi.org\/10.1111\/jdv.12165.","journal-title":"J Eur Acad Dermatology Venereology: JEADV"},{"key":"3082_CR13","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1038\/jid.2009.113","volume":"129","author":"YB Brauchli","year":"2009","unstructured":"Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol. 2009;129:2604\u201312. https:\/\/doi.org\/10.1038\/jid.2009.113.","journal-title":"J Invest Dermatol"},{"key":"3082_CR14","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1046\/j.0022-202x.2001.01520.x","volume":"117","author":"P Boffetta","year":"2001","unstructured":"Boffetta P, Gridley G, Lindel\u00f6f B. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol. 2001;117:1531\u20137. https:\/\/doi.org\/10.1046\/j.0022-202x.2001.01520.x.","journal-title":"J Invest Dermatol"},{"key":"3082_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12951-024-02467-8","volume":"22","author":"M Huai","year":"2024","unstructured":"Huai M, et al. Intelligent nanovesicle for remodeling tumor microenvironment and Circulating tumor chemoimmunotherapy amplification. J Nanobiotechnol. 2024;22:257. https:\/\/doi.org\/10.1186\/s12951-024-02467-8.","journal-title":"J Nanobiotechnol"},{"key":"3082_CR16","doi-asserted-by":"publisher","first-page":"1081919","DOI":"10.3389\/fimmu.2022.1081919","volume":"13","author":"L Ye","year":"2022","unstructured":"Ye L, Shi S, Chen W. Innate immunity in pancreatic cancer: lineage tracing and function. Front Immunol. 2022;13:1081919. https:\/\/doi.org\/10.3389\/fimmu.2022.1081919.","journal-title":"Front Immunol"},{"key":"3082_CR17","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","volume":"375","author":"TN Schumacher","year":"2022","unstructured":"Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer. Sci (New York N Y). 2022;375:eabf9419. https:\/\/doi.org\/10.1126\/science.abf9419.","journal-title":"Sci (New York N Y)"},{"key":"3082_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41423-020-0457-0","volume":"17","author":"L Munoz-Erazo","year":"2020","unstructured":"Munoz-Erazo L, Rhodes JL, Marion VC, Kemp RA. Tertiary lymphoid structures in cancer - considerations for patient prognosis. Cell Mol Immunol. 2020;17:570\u20135. https:\/\/doi.org\/10.1038\/s41423-020-0457-0.","journal-title":"Cell Mol Immunol"},{"key":"3082_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19:307\u201325. https:\/\/doi.org\/10.1038\/s41568-019-0144-6.","journal-title":"Nat Rev Cancer"},{"key":"3082_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita R, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577:561\u20135. https:\/\/doi.org\/10.1038\/s41586-019-1914-8.","journal-title":"Nature"},{"key":"3082_CR21","doi-asserted-by":"publisher","first-page":"783495","DOI":"10.3389\/fimmu.2022.783495","volume":"13","author":"M Zhu","year":"2022","unstructured":"Zhu M, et al. Clinical significance and immunometabolism landscapes of a novel recurrence-associated lipid metabolism signature in early-stage lung adenocarcinoma: a comprehensive analysis. Front Immunol. 2022;13:783495. https:\/\/doi.org\/10.3389\/fimmu.2022.783495.","journal-title":"Front Immunol"},{"key":"3082_CR22","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci: Publ Protein Soc. 2019;28:1947\u201351. https:\/\/doi.org\/10.1002\/pro.3715.","journal-title":"Protein Science: Publication Protein Soc"},{"key":"3082_CR23","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51:D587\u201392. https:\/\/doi.org\/10.1093\/nar\/gkac963.","journal-title":"Nucleic Acids Res"},{"key":"3082_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27.","journal-title":"Nucleic Acids Res"},{"key":"3082_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12967-023-04029-2","volume":"21","author":"P Zhao","year":"2023","unstructured":"Zhao P, Zhen H, Zhao H, Huang Y, Cao B. Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets. J Transl Med. 2023;21:176. https:\/\/doi.org\/10.1186\/s12967-023-04029-2.","journal-title":"J Translational Med"},{"key":"3082_CR26","doi-asserted-by":"publisher","unstructured":"Partyka O, et al. Overview of pancreatic cancer epidemiology in Europe and recommendations for screening in high-risk populations. Cancers. 2023;15. https:\/\/doi.org\/10.3390\/cancers15143634.","DOI":"10.3390\/cancers15143634"},{"key":"3082_CR27","doi-asserted-by":"publisher","first-page":"10258","DOI":"10.1038\/s41598-020-66986-8","volume":"10","author":"M Yi","year":"2020","unstructured":"Yi M, Nissley DV, McCormick F, Stephens RM. SsGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications. Sci Rep. 2020;10:10258. https:\/\/doi.org\/10.1038\/s41598-020-66986-8.","journal-title":"Sci Rep"},{"key":"3082_CR28","doi-asserted-by":"publisher","first-page":"1019638","DOI":"10.3389\/fimmu.2022.1019638","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang Q, et al. Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma. Front Immunol. 2022;13:1019638. https:\/\/doi.org\/10.3389\/fimmu.2022.1019638.","journal-title":"Front Immunol"},{"key":"3082_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7150\/ijbs.66913","volume":"18","author":"D Chen","year":"2022","unstructured":"Chen D, et al. Integrated machine learning and bioinformatic analyses constructed a novel stemness-related classifier to predict prognosis and immunotherapy responses for hepatocellular carcinoma patients. Int J Biol Sci. 2022;18:360\u201373. https:\/\/doi.org\/10.7150\/ijbs.66913.","journal-title":"Int J Biol Sci"},{"key":"3082_CR30","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1186\/s12935-021-02252-9","volume":"21","author":"H Zheng","year":"2021","unstructured":"Zheng H, Liu H, Ge Y, Wang X. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer. Cancer Cell Int. 2021;21:552. https:\/\/doi.org\/10.1186\/s12935-021-02252-9.","journal-title":"Cancer Cell Int"},{"key":"3082_CR31","doi-asserted-by":"publisher","first-page":"109184","DOI":"10.1016\/j.abb.2022.109184","volume":"722","author":"L Imre","year":"2022","unstructured":"Imre L, et al. Nucleosome destabilization by polyamines. Arch Biochem Biophys. 2022;722:109184. https:\/\/doi.org\/10.1016\/j.abb.2022.109184.","journal-title":"Arch Biochem Biophys"},{"key":"3082_CR32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2023.01.002","volume":"186","author":"P Ma","year":"2023","unstructured":"Ma P, et al. Bacterial droplet-based single-cell RNA-seq reveals antibiotic-associated heterogeneous cellular States. Cell. 2023;186:877\u2013e891814. https:\/\/doi.org\/10.1016\/j.cell.2023.01.002.","journal-title":"Cell"},{"key":"3082_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20:131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1.","journal-title":"Mol Cancer"},{"key":"3082_CR34","doi-asserted-by":"publisher","first-page":"102175","DOI":"10.1016\/j.ctrv.2021.102175","volume":"95","author":"E Puliga","year":"2021","unstructured":"Puliga E, Corso S, Pietrantonio F, Giordano S. Microsatellite instability in gastric cancer: between lights and shadows. Cancer Treat Rev. 2021;95:102175. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102175.","journal-title":"Cancer Treat Rev"},{"key":"3082_CR35","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41591-019-0462-y","volume":"25","author":"JN Kather","year":"2019","unstructured":"Kather JN, et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat Med. 2019;25:1054\u20136. https:\/\/doi.org\/10.1038\/s41591-019-0462-y.","journal-title":"Nat Med"},{"key":"3082_CR36","doi-asserted-by":"publisher","first-page":"e1034","DOI":"10.1210\/clinem\/dgad218","volume":"108","author":"Z Zhuang","year":"2023","unstructured":"Zhuang Z, et al. Sleep patterns, plasma metabolome, and risk of incident type 2 diabetes mellitus. J Clin Endocrinol Metab. 2023;108:e1034\u201343. https:\/\/doi.org\/10.1210\/clinem\/dgad218.","journal-title":"J Clin Endocrinol Metab"},{"key":"3082_CR37","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1002\/cam4.3240","volume":"9","author":"S Sun","year":"2020","unstructured":"Sun S, et al. Development and validation of an immune-related prognostic signature in lung adenocarcinoma. Cancer Med. 2020;9:5960\u201375. https:\/\/doi.org\/10.1002\/cam4.3240.","journal-title":"Cancer Med"},{"key":"3082_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.athoracsur.2022.03.044","volume":"114","author":"A Hage","year":"2022","unstructured":"Hage A, Hage F. Kaplan-Meier survival, actuarial survival, censoring, and competing events-what is what? Ann Thorac Surg. 2022;114:40\u20133. https:\/\/doi.org\/10.1016\/j.athoracsur.2022.03.044.","journal-title":"Ann Thorac Surg"},{"key":"3082_CR39","doi-asserted-by":"publisher","first-page":"108296","DOI":"10.1016\/j.celrep.2020.108296","volume":"33","author":"C Tlemsani","year":"2020","unstructured":"Tlemsani C, et al. SCLC-CellMiner: a resource for small cell lung cancer cell line genomics and Pharmacology based on genomic signatures. Cell Rep. 2020;33:108296. https:\/\/doi.org\/10.1016\/j.celrep.2020.108296.","journal-title":"Cell Rep"},{"key":"3082_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","volume":"14","author":"Y Lei","year":"2021","unstructured":"Lei Y, et al. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol. 2021;14:91. https:\/\/doi.org\/10.1186\/s13045-021-01105-2.","journal-title":"J Hematol Oncol"},{"key":"3082_CR41","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s11427-022-2240-6","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Overview and countermeasures of cancer burden in China. Sci China Life Sci. 2023;66:2515\u201326. https:\/\/doi.org\/10.1007\/s11427-022-2240-6.","journal-title":"Sci China Life Sci"},{"key":"3082_CR42","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s11427-022-2218-x","volume":"66","author":"W Ju","year":"2023","unstructured":"Ju W, et al. Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, japan, and the Republic of Korea. Sci China Life Sci. 2023;66:1079\u201391. https:\/\/doi.org\/10.1007\/s11427-022-2218-x.","journal-title":"Sci China Life Sci"},{"key":"3082_CR43","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729\u201354. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014.","journal-title":"Cell"},{"key":"3082_CR44","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","volume":"5","author":"EM O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly EM, et al. Durvalumab with or without Tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial. JAMA Oncol. 2019;5:1431\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2019.1588.","journal-title":"JAMA Oncol"},{"key":"3082_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00281-024-01034-5","volume":"47","author":"CT Berry","year":"2025","unstructured":"Berry CT, et al. Current advancements in cellular immunotherapy for autoimmune disease. Semin Immunopathol. 2025;47:7. https:\/\/doi.org\/10.1007\/s00281-024-01034-5.","journal-title":"Semin Immunopathol"},{"key":"3082_CR46","doi-asserted-by":"publisher","first-page":"1222719","DOI":"10.3389\/fimmu.2023.1222719","volume":"14","author":"X Zou","year":"2023","unstructured":"Zou X, et al. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. Front Immunol. 2023;14:1222719. https:\/\/doi.org\/10.3389\/fimmu.2023.1222719.","journal-title":"Front Immunol"},{"key":"3082_CR47","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1136\/gutjnl-2022-328697","volume":"72","author":"GS Kinker","year":"2023","unstructured":"Kinker GS, et al. Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas. Gut. 2023;72:1927\u201341. https:\/\/doi.org\/10.1136\/gutjnl-2022-328697.","journal-title":"Gut"},{"key":"3082_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-024-01980-6","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application. Mol Cancer. 2024;23:75. https:\/\/doi.org\/10.1186\/s12943-024-01980-6.","journal-title":"Mol Cancer"},{"key":"3082_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-024-02191-9","volume":"24","author":"BH Jenkins","year":"2025","unstructured":"Jenkins BH, et al. Single cell and Spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response. Mol Cancer. 2025;24:3. https:\/\/doi.org\/10.1186\/s12943-024-02191-9.","journal-title":"Mol Cancer"},{"key":"3082_CR50","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s43018-024-00731-2","volume":"5","author":"Y Astuti","year":"2024","unstructured":"Astuti Y, et al. Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. Nat cancer. 2024;5:774\u201390. https:\/\/doi.org\/10.1038\/s43018-024-00731-2.","journal-title":"Nat cancer"},{"key":"3082_CR51","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/cddiscovery.2017.71","volume":"3","author":"M Cassandri","year":"2017","unstructured":"Cassandri M, et al. Zinc-finger proteins in health and disease. Cell Death Discov. 2017;3:17071. https:\/\/doi.org\/10.1038\/cddiscovery.2017.71.","journal-title":"Cell Death Discovery"},{"key":"3082_CR52","doi-asserted-by":"publisher","first-page":"e23157","DOI":"10.1096\/fj.202300801R","volume":"37","author":"J Zhao","year":"2023","unstructured":"Zhao J, Wen D, Zhang S, Jiang H, Di X. The role of zinc finger proteins in malignant tumors. FASEB J: Off Publ Federn Am Soc Exp Biol. 2023;37:e23157. https:\/\/doi.org\/10.1096\/fj.202300801R.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"3082_CR53","doi-asserted-by":"publisher","unstructured":"Wang H, et al. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target. J Immunother Cancer. 2022;10. https:\/\/doi.org\/10.1136\/jitc-2021-004302.","DOI":"10.1136\/jitc-2021-004302"},{"key":"3082_CR54","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1186\/s12885-023-11308-0","volume":"23","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer. BMC Cancer. 2023;23:925. https:\/\/doi.org\/10.1186\/s12885-023-11308-0.","journal-title":"BMC Cancer"},{"key":"3082_CR55","doi-asserted-by":"publisher","unstructured":"Mukherjee S, et al. Familiarity breeds strategy: in Silico untangling of the molecular complexity on course of autoimmune liver disease-to-hepatocellular carcinoma transition predicts novel transcriptional signatures. Cells. 2021;10. https:\/\/doi.org\/10.3390\/cells10081917.","DOI":"10.3390\/cells10081917"},{"key":"3082_CR56","doi-asserted-by":"publisher","unstructured":"Najjar R, et al. Large overlap in neutrophil transcriptome between lupus and COVID-19 with limited lupus-specific gene expression. Lupus Sci Med. 2024;11. https:\/\/doi.org\/10.1136\/lupus-2023-001059.","DOI":"10.1136\/lupus-2023-001059"},{"key":"3082_CR57","doi-asserted-by":"publisher","first-page":"e11423","DOI":"10.7717\/peerj.11423","volume":"9","author":"B Liu","year":"2021","unstructured":"Liu B, et al. GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma. PeerJ. 2021;9:e11423. https:\/\/doi.org\/10.7717\/peerj.11423.","journal-title":"PeerJ"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03082-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03082-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03082-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:51:04Z","timestamp":1751374264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03082-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3082"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03082-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1247"}}